查看完整行情页>>

|

货币单位:美元(USD)

Nevro Corp. (nvro)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Rebecca Palbicki Rebecca Palbicki currently works as a Vice President of Information Technology at Nevro Corp.
Kashif Rashid Kashif Rashid is currently the Director at Nevro Medical Ltd. and the Chief Legal Officer & SVP-Corporate Development at Nevro Corp. Previously, he worked as the Deputy General Counsel at St. Jude Medical, Inc. (Texas) from 2008 to 2017. He also served as the Vice President-Legal at Atara Biotherapeutics, Inc. in 2017. Mr. Rashid completed his undergraduate degree at George Washington University and his graduate degree at Georgetown University Law Center.
Christopher Christoforou Christopher Christoforou is currently working as the Senior Vice President-Technical Operations at Nevro Corp. Prior to his current position, he worked as the Vice President-Quality Engineering at Thoratec Corp from 1999 to 2016. Before that, he was an Engineering Manager at United States Surgical Corp from 1993 to 1999. Mr. Christoforou completed his undergraduate degree at Boston University and his graduate degree at The Johns Hopkins University.
David Caraway David Caraway is currently the Chief Medical Officer & Senior Vice President at Nevro Corp. Prior to this, he was the Chief Executive Officer at Center For Pain Relief and Tristate LLC from 2001 to 2014. Dr. Caraway holds a doctorate degree from The University of Virginia School of Medicine and The College & Graduate School of Arts & Sciences, and an undergraduate degree from the School of Engineering & Applied Science.
Richard B. Carter Richard B. Carter is currently the Chief Accounting Officer at Nevro Corp. He previously worked as an Auditor at Ernst & Young LLP from 1993 to 1996. From 1998 to 2004, he served as the Corporate Controller at Transmeta Corp. He then worked as the Corporate Controller at PortalPlayer, Inc. from 2005 to 2007. From 2013 to 2015, he held the position of Corporate Controller at Doosan Fuel Cell America, Inc. Prior to that, he was the Vice President-Finance & Controller at Kovio, Inc. from 2011 to 2013. From 2007 to 2011, he served as the Vice President-Finance & Controller at MiaSolé, Inc. Mr. Carter obtained his undergraduate degree from The California State University.
Roderick H. MacLeod Roderick H. MacLeod joined us in June 2020 and currently serves as our Senior Vice President and Chief Financial Officer. From September 2004 to June 2020, Mr. MacLeod served in leadership positions at Stryker Endoscopy, a division of Stryker Corp (“Stryker”) that develops and manufactures medical devices, most recently as Vice President of Finance. Prior to joining Stryker, Mr. MacLeod served in various finance positions at Lumenare Networks, United Airlines and Arthur Andersen & Co. Mr. MacLeod received a B.A. in Economics from Harvard University and a Master of Management degree from Northwestern University’s J.L. Kellogg Graduate School of Management.
Geeta Kaveti Geeta Kaveti currently works at Nevro Corp., as Vice President, Chief Compliance & Privacy Officer.
Shana D. Ross Shana D. Ross is currently the Chief Human Resources Officer & Senior VP at Nevro Corp. Prior to this, she worked as the VP-Human Resources & Chief Diversity Officer at Bayhealth Medical Center, Inc. She holds a graduate degree and an MBA from the University of Maryland.
Greg Siller Greg Siller is currently working as the Chief Commercial Officer & Senior Vice President at Nevro Corp. He completed his undergraduate degree at the University of New Hampshire.
Kerry Bradley Kerry Bradley has a current job as Vice President-Scientific Affairs at Nevro Corp.
Michael F. DeMane Michael F. DeMane is currently a Director at Rotation Medical, Inc., Lead Independent Director at Nevro Corp., and Director at Cardionomic, Inc. Previously, he served as Chairman & Chief Executive Officer at Lanx, Inc. in 2010, Independent Director at ERT Operating Co. from 2008 to 2012, Director at Torax Medical, Inc., Director at Synaptive Medical, Inc., and Independent Director at Safe SA (France) from 2014 to 2019. He also held the position of Managing Director at Smith & Nephew Pty Ltd. (Australia) and Smith & Nephew Pty Ltd. (New Zealand) from 1996 to 1998, Director at Eresearch Technologies, Inc. from 2008 to 2012, and Chief Operating Officer at Medtronic, Inc. from 2007 to 2008. Additionally, he served as President-Orthopedic Implant Division at Smith & Nephew Orthopaedics Ltd. from 1993 to 1996 and President-Interbody Technologies at Medtronic Sofamor Danek, Inc. from 1998 to 1999. Mr. DeMane holds a graduate degree from Clemson University and an undergraduate degree from St. Lawrence University.
Donald A. Middlebrook Donald A. Middlebrook is currently the Senior VP-Clinical & Regulatory Affairs at Nevro Corp. He previously held positions as Chairman & President at Regulatory Affairs Professionals Society, Senior Director-Global Regulatory Affairs at Chiron Vision Corp., VP-Regulatory Affairs & Quality Assurance at Baxter International, Inc., and VP-Regulatory Affairs & Quality Assurance at Thoratec Corp. He also worked at Cardiovascular Group in the role of VP-Regulatory Affairs & Quality Assurance. Mr. Middlebrook obtained his undergraduate degree from California State University-Fullerton.
D. Keith Grossman D. Keith Grossman is currently the Vice Chairman at Alcon AG, the Executive Chairman at Nevro Corp., and the Lead Independent Director at Outset Medical, Inc. He is also a Director at Alcon NV, Vyaire Holding Co., and Alcon Vision LLC. In the past, Mr. Grossman served as the President & Chief Executive Officer of Thoratec Corp. from 2014 to 2015. He was also the President, Chief Executive Officer & Director of Conceptus, Inc. from 2011 to 2013. Additionally, he served as a Director at Intuitive Surgical, Inc. from 2003 to 2010 and as a Director at Medtronic Spine LLC in 2007. He has also held director positions at Acorn Cardiovascular, Inc. and Vibrynt, Inc. Furthermore, Mr. Grossman served as the Lead Independent Director at ZELTIQ Aesthetics, Inc. from 2016 to 2017. He was a Director at Tandem Diabetes Care, Inc. and Conventus Orthopaedics, Inc. from 2010 to 2012. He also served as a Director at NovaSom, Inc. from 2008 to 2012 and at PatientSafe Solutions, Inc. from 2009 to 2012. Mr. Grossman was a Managing Director at TPG Capital LLC from 2007 to 2011 and at TPG Biotech from 2007 to 2011. He was also a Managing Director at TPG Capital LP from 2007 to 2011. He served as a Director at The Medical Device Manufacturers Association from 2011 to 2014 and at the Kyphon, Inc. in 2007. Additionally, Mr. Grossman held the position of Division President at MAJOR Pharmaceuticals, Inc. from 1992 to 1995 and Vice President-Sales & Marketing at Calcitek, Inc. from 1988 to 1992. He was also the Head-Sales & Marketing at McGaw Laboratories. Mr. Grossman received his undergraduate degree from The Ohio State University in 1983 and his MBA from Pepperdine Graziadio Business School in 1992.
Kevin R. Thornal Kevin R. Thornal is currently the President, Chief Executive Officer & Director at Nevro Corp. Prior to his current position, he served as the Group President-Global Diagnostics Solutions at Hologic, Inc. Mr. Thornal completed his undergraduate degree at Southern Methodist University.
Karen Naomi Prange Karen Naomi Prange is currently serving as an Independent Director in AtriCure, Inc., ViewRay, Inc., Nevro Corp., WS Audiology A, and Embecta Corp. She is also a Member of The Committee of 200. In the past, she served as EVP and CEO-Global Animal Health & Medical Group in Henry Schein, Inc., Independent Director in Cantel Medical LLC, GM-Micrus Endovascular & Codman Neurovascula in Johnson & Johnson, and SVP and President-Urology & Women's Health in Boston Scientific Corp. Ms. Prange completed her undergraduate degree from the University of Florida.
Elizabeth H. Weatherman Elizabeth H. Weatherman is currently an Independent Director at Vapotherm, Inc. and Silk Road Medical, Inc. She is also a Director at International Technidyne Corp., ReSearch Pharmaceutical Services LLC, Bacchus Vascular, Inc., Insulet Corp., Nevro Corp., Adlens Beacon Corp, Monterey Advisors, Inc., and Accriva Diagnostics, Inc. Additionally, she serves as a Trustee at Stanford University, Mount Holyoke College, and Saint Ann's School. Ms. Weatherman is a Special Limited Partner at Warburg Pincus LLC and an Advisor at Avestria Ventures Management, LLC. In her former roles, she was a Director at Medtronic Spine LLC, Wright Medical Group, Inc., ev3, Inc., Specialists On Call, Inc., Bausch & Lomb Holdings, Inc., Outset Medical, Inc., Keystone Dental, Inc., National Venture Capital Association, Par Sterile Products LLC, and ComplexCare Solutions, Inc. She was also a Non-Executive Director at Tornier NV and an Independent Non-Executive Director at Wright Medical Group NV. Ms. Weatherman was a General Partner at Warburg Pincus & Company US LLC and a Member of Executive Management Group LLC. She completed her undergraduate studies at Mount Holyoke College and holds an MBA from Stanford Graduate School of Business.
Kevin C. O'Boyle Kevin C. O'Boyle currently works at Nevro Corp., as Independent Director from 2019, San Diego Hall of Champions, as Director, ChromaCode, Inc., as Director from 2021, HighCape Partners Management LLC, as Advisor, and HighCape Capital Acquisition Corp. II, as Advisor from 2020. Mr. O'Boyle also formerly worked at GenMark Diagnostics, Inc., as Chairman from 2020 to 2021, NeoTract, Inc., as Director in 2017, ZELTIQ Aesthetics, Inc., as Independent Director from 2011 to 2017, Tornier NV, as Independent Non-Executive Director from 2013 to 2019, Sientra, Inc., as Independent Director from 2014 to 2023, Durata Therapeutics, Inc., as Independent Director from 2012 to 2014, Wright Medical Group NV, as Independent Non-Executive Director from 2010 to 2020, Clarient, Inc., as Chief Financial Officer & Senior VP-Operations, NuVasive, Inc., as Chief Financial Officer from 2003 to 2009, Chroma Vision Medical Systems, Inc., as Chief Financial & Operating Officer, Shire Regenerative Medicine, Inc., as Chief Financial Officer & Senior Vice President from 2010 to 2011, Albert Fisher Group Plc, as Chief Financial Officer & SVP-Operations, Albert Fisher North America, Inc., as Chief Financial Officer & SVP-Operations, American Cablesystems Corp., as Vice President & Controller, and HighCape Capital Acquisition Corp., as Advisor. Mr. O'Boyle received his undergraduate degree from Rochester Institute of Technology.
Frank M. Fischer Frank M. Fischer is the founder and currently holds the position of Chairman at NeuroPace, Inc., which was founded in 1997. He is also currently serving as Chairman at TherOx, Inc. since 1997, Director at Proteus Digital Health, Inc., Director at Epilepsy Foundation, Independent Director at Nevro Corp. since 2012, Trustee at Babson College, and Trustee at Rensselaer Polytechnic Institute. In his former positions, Mr. Fischer served as President, Chief Executive Officer & Director at Ventritex, Inc. from 1987 to 1997, President, Chief Executive Officer & Director at Heartport, Inc. from 1998 to 1999, Chairman & Chief Executive Officer at Aruene Corp., Chairman at Autonomic Technologies, Inc., Independent Director at TENON Medical, Inc. from 2022 to 2023, Director at Leptos Biomedical, Inc., Director at Avertix Medical Systems, Inc., and President-Implantable Products Division at Cordis Corp. from 1977 to 1987. He also worked as a Principal at GE Aerospace and served as an Advisor at Aphelion Capital LLC. Mr. Fischer received his undergraduate and graduate degrees from Rensselaer Polytechnic Institute.
Sridhar Kosaraju Sridhar Kosaraju is currently the President, Chief Executive Officer & Director at Inscripta, Inc., an Independent Director at 10X Genomics, Inc., and an Independent Director at Nevro Corp. He is also a Director at Testing For America. Previously, he worked at JPMorgan Securities LLC as a Managing Director-Equity Capital Markets from 1999 to 2015, and at Penumbra, Inc. as the President from 2019 to 2020. Mr. Kosaraju received his undergraduate degree from the Massachusetts Institute of Technology in 1999.
Susan E. Siegel Susan E. Siegel is the founder of Stanford Health Care. She currently holds the position of Chairman & Board of Director at The Engine Accelerator, Inc. and Co-Chairman at Stanford Medicine. Additionally, she serves as an Independent Director at Illumina, Inc., Align Technology, Inc., the University of California, Berkeley, The Tech Interactive, RAND Health, Nevro Corp., National Center for Advancing Translational Sciences, Kaiser Family Foundation, Center for Strategic & International Studies, Inc., The National Academies of Science, Women Corporate Directors, and the University of California. She is also a Council Member-Biotechnology Research at the Center for Strategic & International Studies, Inc. and a Member-Presidents Council at The National Academies of Science. In her former positions, Ms. Siegel served as the Chief Innovation Officer & CEO-Business Innovations at GE Aerospace. She was also the President & Director at Affymetrix, Inc., an Independent Director at Pacific Biosciences of California, Inc., and a Director at Crescendo Bioscience LLC, Cellective Dx Corp., RainDance Technologies, Inc., Medtronic Monitoring, Inc., Analyte Health, Inc., DVS Sciences, Inc., The Brigham & Women's Hospital, Inc., and the University of California, Berkeley. She held the position of Director-Baker Bioenginuity Hub at the University of California, Berkeley. Additionally, she served as a Director at National Venture Capital Association, Life Technologies Clinical Services Lab, Inc., On-Q-ity, Inc., Silicon Valley Technical Institute, Bio-Rad Laboratories, Inc., EIDP, Inc., and Global Life Sciences Solutions USA LLC. She was the Chief Innovation Officer at GE Ventures LLC and a Partner at MDV Management Co. LLC. She also served as the President of Hoefer Pharmacia Biotech, Inc. Ms. Siegel completed her undergraduate studies at the University of Puerto Rico and her graduate studies at Boston University School of Medicine.
Shawn T. McCormick Shawn T. McCormick is an Independent Director at Nevro Corp., Inspire Medical Systems, Inc., and Advisor at Vensana Capital Management LLC. He previously served as an Independent Director at Surmodics, Inc., Entellus Medical, Inc., and Director at Lanx, Inc. He also held the position of Vice President-Corporate Development at Medtronic, Inc. and Chief Financial Officer & Senior Vice President at ev3, Inc. Additionally, he worked as a Principal at KPMG Peat Marwick LLP and Chief Financial Officer at Tornier NV and Tornier, Inc. He was also the Chief Financial Officer at Wright Medical Group NV and Aldevron LLC. Prior to that, he served as the Chief Operating Officer at Lutonix, Inc. Mr. McCormick obtained an undergraduate degree from Arizona State University and an MBA from The Curtis L. Carlson School of Management.